Tirzepatide
Tirzepatide is Eli Lilly’s dual GLP-1 and GIP receptor agonist. Marketed as Mounjaro for T2D and Zepbound for weight loss (plus obstructive sleep apnea since 2024), it consistently outperforms semaglutide in head-to-head trials. We cover why dual-agonist works better, the SURMOUNT and SURPASS trial data, and which patients see the strongest results.
Mounjaro Cost (2026): Why It’s Pricier Than Zepbound
"How much does Mounjaro cost" has no single answer. Mounjaro is FDA-approved for type 2 diabetes — and that one…
Latest in Tirzepatide
Semaglutide vs Tirzepatide: Which Drops More Weight?
Semaglutide and tirzepatide are the two molecules behind every major GLP-1 brand. The first head-to-head trial showed tirzepatide loses more…
Compounded Semaglutide from $147/month
LegitScript-certified · 503A US pharmacy · 1-2 day shipping · Available in 48 states
More from Tirzepatide
Mounjaro (2026): Dose, Cost, and Side Effects
Affiliate disclosure: This article contains affiliate links. We may earn commission when you purchase through…